2,949
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma

ORCID Icon, , , , &
Pages 673-681 | Received 08 Dec 2020, Accepted 15 Jan 2021, Published online: 23 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jie Hao, Yu Liu, Fengli Guo, Guiming Fu, Junya Ning, Xianhui Ruan, Xiangqian Zheng & Ming Gao. (2023) Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway. International Journal of General Medicine 16, pages 5651-5664.
Read now

Articles from other publishers (8)

Zuchao Hu, Zhen Chen, Wei Jiang, Dazheng Fang, Ping Peng, Shouguo Yao, Ming Luo, Lei Wang, Zhengfu Sun, Wei Wang, Xin Wang, Haibo Mao, Fen Ai & Peihua Zhou. (2023) Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB. Biochemical Genetics 61:6, pages 2672-2690.
Crossref
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice & Alessandro Federico. (2023) Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers 15:21, pages 5178.
Crossref
Jing Dai, Xiang Dong, Yuxin Chen, Wanying Xue, Qingqing Wang, Feifei Shang, Yunxia Zhao, Shujing Li, Yu Gao & Yuanyuan Wang. (2023) SPOP regulates the expression profiles and alternative splicing events in human hepatocytes. Open Life Sciences 18:1.
Crossref
Wanying Chen, Kexin Shu, Chenxi Cai, Jiatong Ding, Xin Zhang, Wenxiong Zhang & Kang Wang. (2023) Prognostic value and immune landscapes of immunogenic cell death-related lncRNAs in hepatocellular carcinoma. Bioscience Reports 43:9.
Crossref
Wanshan Ma, Xiaoyu Zhang, Jing Lu, Shiyu Lv, Zhenyu Zhang, Hongxin Ma, Qianqian Chen, Wenjing Cao & Xiaoning Zhang. (2023) Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma. Molecular Carcinogenesis 62:9, pages 1295-1311.
Crossref
Mona A. Omar, Mohamed M. Omran, Khaled Farid, Ashraf A. Tabll, Yasser E. Shahein, Tarek M. Emran, Ana Petrovic, Nikola R. Lucic, Robert Smolic, Tanja Kovac & Martina Smolic. (2023) Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines 11:7, pages 1852.
Crossref
Mehrdad Hashemi, Sepideh Mirzaei, Mohammad Arad Zandieh, Sahar Rezaei, Amirabbas kakavand, Amir Dehghanpour, Negin Esmaeili, Azin Ghahremanzade, Hamidreza Saebfar, Hajar Heidari, Shokooh Salimimoghadam, Afshin Taheriazam, Maliheh Entezari & Kwang Seok Ahn. (2023) Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology 177, pages 207-228.
Crossref
Ting-Ting Liu, Rui Li, Chen Huo, Jian-Ping Li, Jie Yao, Xiu-li Ji & Yi-Qing Qu. (2021) Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis. Frontiers in Cell and Developmental Biology 9.
Crossref